Management of onychomycosis in children

Antonella Tosti1, Bianca Maria Piraccini, Matilde Iorizzo

  • 1Department of Dermatology, University of Bologna, Via Massarenti 1, 40138 Bologna, Italy. tosti@almadns.unibo.it

Dermatologic Clinics
|September 6, 2003
PubMed

Insights

Terbinafine, itraconazole, and fluconazole are effective treatments for pediatric onychomycosis. Dosages are weight-based, and treatment duration matches adult protocols for these common fungal nail infections.

Area of Science:

  • Mycology
  • Pediatric Dermatology
  • Pharmacology

Background:

  • Onychomycosis, a fungal nail infection, affects children.
  • Systemic antifungal therapies are options for pediatric onychomycosis.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of systemic antifungal agents for pediatric onychomycosis.

Main Methods:

  • Review of clinical data on terbinafine, itraconazole, and fluconazole use in children.
  • Analysis of dosage guidelines and treatment durations.

Main Results:

  • Terbinafine, itraconazole, and fluconazole demonstrate effectiveness in treating pediatric onychomycosis.
  • These antifungals are well-tolerated in the pediatric population.
  • Dosage is determined by body weight, a key factor in pediatric prescribing.

Conclusions:

  • Systemic antifungal medications are a viable treatment for children with onychomycosis.
  • Weight-based dosing ensures appropriate therapeutic levels.
  • Consistent treatment duration with adult protocols simplifies management.

Related Concept Videos

Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...